Tuberculin skin test and interferon‐γ release assays: Can they agree?
Abstract Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | The Clinical Respiratory Journal |
Subjects: | |
Online Access: | https://doi.org/10.1111/crj.13569 |
_version_ | 1797935993962102784 |
---|---|
author | João Almeida Santos Raquel Duarte Carla Nunes |
author_facet | João Almeida Santos Raquel Duarte Carla Nunes |
author_sort | João Almeida Santos |
collection | DOAJ |
description | Abstract Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic. Objectives To characterize the agreement between the IGRA and TST tests by determining the kappa coefficient (K) and agreement rate between these two tests in patients with active tuberculosis (TB). Methods Retrospective cohort study conducted with data from active TB patients notified in the Portuguese Tuberculosis Surveillance System (SVIG‐TB), from 2008 to 2015. TST results were interpreted using a 5 mm (TST‐5 mm) and 10 mm (TST‐10 mm) cutoff. Kappa coefficient and agreement rate were calculated in order to evaluate the agreement between IGRA and TST (both cutoffs) test results. Results A total of 727 patients with results for both tests were included in the study, of which 3.4% (n = 25) had HIV infection, 5.6% (n = 41) diabetes, 5.0% (n = 36) oncological diseases and 4.4% (n = 32) inflammatory diseases. Of the 727 patients, 16.5% (n = 120) presented different outcomes between IGRA and TST‐5 mm, and 20.5% (n = 149) presented different outcomes between IGRA and TST‐10 mm. Kappa coefficient between IGRA and TST‐5 mm was 0.402 (p < 0.001) with an agreement rate of 83.5%. Between IGRA and TST‐10 mm, the kappa coefficient was 0.351 (p < 0.001), with an agreement rate of 79.5%. Patients with HIV infection, diabetes, oncologic diseases and inflammatory diseases presented a substantial agreement between IGRA and TST‐5 mm, while inflammatory diseases was the only variable that presented a substantial agreement between IGRA and TST‐10 mm. Conclusion As both tests can present false‐negative results, the low level of agreement between the tests can potentially help identify more cases of LTBI if the two tests are used in parallel, with infections not detected by IGRA possibly being detected by the TST and vice versa. |
first_indexed | 2024-04-10T18:23:49Z |
format | Article |
id | doaj.art-c70e6e07797e47acbbddcf3cc18f070b |
institution | Directory Open Access Journal |
issn | 1752-6981 1752-699X |
language | English |
last_indexed | 2024-04-10T18:23:49Z |
publishDate | 2023-02-01 |
publisher | Wiley |
record_format | Article |
series | The Clinical Respiratory Journal |
spelling | doaj.art-c70e6e07797e47acbbddcf3cc18f070b2023-02-02T06:54:36ZengWileyThe Clinical Respiratory Journal1752-69811752-699X2023-02-0117210911410.1111/crj.13569Tuberculin skin test and interferon‐γ release assays: Can they agree?João Almeida Santos0Raquel Duarte1Carla Nunes2NOVA National School of Public Health, Public Health Research Centre Universidade NOVA de Lisboa Lisbon PortugalCentro Hospitalar de Vila Nova de Gaia Vila Nova de Gaia PortugalNOVA National School of Public Health, Public Health Research Centre Universidade NOVA de Lisboa Lisbon PortugalAbstract Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic. Objectives To characterize the agreement between the IGRA and TST tests by determining the kappa coefficient (K) and agreement rate between these two tests in patients with active tuberculosis (TB). Methods Retrospective cohort study conducted with data from active TB patients notified in the Portuguese Tuberculosis Surveillance System (SVIG‐TB), from 2008 to 2015. TST results were interpreted using a 5 mm (TST‐5 mm) and 10 mm (TST‐10 mm) cutoff. Kappa coefficient and agreement rate were calculated in order to evaluate the agreement between IGRA and TST (both cutoffs) test results. Results A total of 727 patients with results for both tests were included in the study, of which 3.4% (n = 25) had HIV infection, 5.6% (n = 41) diabetes, 5.0% (n = 36) oncological diseases and 4.4% (n = 32) inflammatory diseases. Of the 727 patients, 16.5% (n = 120) presented different outcomes between IGRA and TST‐5 mm, and 20.5% (n = 149) presented different outcomes between IGRA and TST‐10 mm. Kappa coefficient between IGRA and TST‐5 mm was 0.402 (p < 0.001) with an agreement rate of 83.5%. Between IGRA and TST‐10 mm, the kappa coefficient was 0.351 (p < 0.001), with an agreement rate of 79.5%. Patients with HIV infection, diabetes, oncologic diseases and inflammatory diseases presented a substantial agreement between IGRA and TST‐5 mm, while inflammatory diseases was the only variable that presented a substantial agreement between IGRA and TST‐10 mm. Conclusion As both tests can present false‐negative results, the low level of agreement between the tests can potentially help identify more cases of LTBI if the two tests are used in parallel, with infections not detected by IGRA possibly being detected by the TST and vice versa.https://doi.org/10.1111/crj.13569interferon‐gamma release testslatent tuberculosis infectionpublic healthtuberculin skin test |
spellingShingle | João Almeida Santos Raquel Duarte Carla Nunes Tuberculin skin test and interferon‐γ release assays: Can they agree? The Clinical Respiratory Journal interferon‐gamma release tests latent tuberculosis infection public health tuberculin skin test |
title | Tuberculin skin test and interferon‐γ release assays: Can they agree? |
title_full | Tuberculin skin test and interferon‐γ release assays: Can they agree? |
title_fullStr | Tuberculin skin test and interferon‐γ release assays: Can they agree? |
title_full_unstemmed | Tuberculin skin test and interferon‐γ release assays: Can they agree? |
title_short | Tuberculin skin test and interferon‐γ release assays: Can they agree? |
title_sort | tuberculin skin test and interferon γ release assays can they agree |
topic | interferon‐gamma release tests latent tuberculosis infection public health tuberculin skin test |
url | https://doi.org/10.1111/crj.13569 |
work_keys_str_mv | AT joaoalmeidasantos tuberculinskintestandinterferongreleaseassayscantheyagree AT raquelduarte tuberculinskintestandinterferongreleaseassayscantheyagree AT carlanunes tuberculinskintestandinterferongreleaseassayscantheyagree |